CA3005120A1 - Nouvelles molecules issues d'algues marines a activite anticancereuse - Google Patents

Nouvelles molecules issues d'algues marines a activite anticancereuse Download PDF

Info

Publication number
CA3005120A1
CA3005120A1 CA3005120A CA3005120A CA3005120A1 CA 3005120 A1 CA3005120 A1 CA 3005120A1 CA 3005120 A CA3005120 A CA 3005120A CA 3005120 A CA3005120 A CA 3005120A CA 3005120 A1 CA3005120 A1 CA 3005120A1
Authority
CA
Canada
Prior art keywords
compound
cancer
composition
mammal
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3005120A
Other languages
English (en)
Inventor
Judith BOBBITT
Ahmed ZEIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oceans Ltd
Original Assignee
Oceans Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oceans Ltd filed Critical Oceans Ltd
Publication of CA3005120A1 publication Critical patent/CA3005120A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02—Monosaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des composés purifiés extraits d'algues marines de formule (I) dans laquelle R1 et R2 représentent chacun indépendamment H ou un acide gras et leur utilisation pour inhiber la croissance de cellules cancéreuses.
CA3005120A 2015-11-17 2016-11-16 Nouvelles molecules issues d'algues marines a activite anticancereuse Pending CA3005120A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562256339P 2015-11-17 2015-11-17
US62/256,339 2015-11-17
US201562269198P 2015-12-18 2015-12-18
US62/269,198 2015-12-18
PCT/CA2016/051333 WO2017083967A1 (fr) 2015-11-17 2016-11-16 Nouvelles molécules issues d'algues marines à activité anticancéreuse

Publications (1)

Publication Number Publication Date
CA3005120A1 true CA3005120A1 (fr) 2017-05-26

Family

ID=58717218

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3005120A Pending CA3005120A1 (fr) 2015-11-17 2016-11-16 Nouvelles molecules issues d'algues marines a activite anticancereuse

Country Status (4)

Country Link
US (2) US20190185501A1 (fr)
EP (1) EP3377509B1 (fr)
CA (1) CA3005120A1 (fr)
WO (1) WO2017083967A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102135797B1 (ko) * 2018-07-16 2020-07-20 경희대학교 산학협력단 아욱 유래 글리코실 글리세라이드를 포함하는 암 예방 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019716A (ja) * 1983-07-11 1985-01-31 Takeda Chem Ind Ltd 抗腫瘍剤
AU6821294A (en) * 1993-04-30 1994-11-21 Rodner R. Winget Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
JPH07149786A (ja) * 1993-11-26 1995-06-13 Sagami Chem Res Center グリセロ糖脂質及び発癌プロモーター阻害剤
JP4820617B2 (ja) * 2005-10-21 2011-11-24 微生物利用新機能物質生産技術研究組合 害虫摂食阻害剤及び方法
US10420808B2 (en) * 2014-07-21 2019-09-24 Oceans Ltd. Seaweed extract and composition useful against cancer cells

Also Published As

Publication number Publication date
US20200291054A1 (en) 2020-09-17
EP3377509B1 (fr) 2021-09-01
WO2017083967A1 (fr) 2017-05-26
US11292807B2 (en) 2022-04-05
US20190185501A1 (en) 2019-06-20
EP3377509A4 (fr) 2019-07-31
EP3377509A1 (fr) 2018-09-26

Similar Documents

Publication Publication Date Title
ES2698620T3 (es) Icaritina para uso en la prevención o el tratamiento de la hematocitopenia
EP2983673A2 (fr) Thérapie contre le cancer
US20130079401A1 (en) Novel use of isothiocyanates for treating cancer
WO2017092230A1 (fr) Composé de biflavone et utilisations de celui-ci pour le traitement de cancers et la préparation de médicaments
ES2279157T3 (es) Extracto con actividad antitumoral y antivenenosa.
AU2015352042B2 (en) Titled extracts of Cynara scolymus for use in the treatment of mesothelioma
CA3009533A1 (fr) Nouvelle molecule a activite anti-cancereuse
CN104311519A (zh) 具有胃黏膜损伤保护作用的功能性食品因子制备及其应用
CA3005120A1 (fr) Nouvelles molecules issues d'algues marines a activite anticancereuse
CN105663147B (zh) 4-羟基水杨酰苯胺在制备抗肿瘤药物中的应用
EP2595627B1 (fr) Utilisation de l'uléine pour la prévention et/ou le traitement du sida
US9629866B2 (en) Use of cordycepin in manufacture of medicaments for anti-depression
CN106928298A (zh) 环二核苷酸cGAMP衍生物的结构组成、制备方法及其在抗肿瘤中的应用
CN104146999B (zh) 冬凌草甲素和多烯紫杉醇减毒增效抗肿瘤药物组合物及其应用
TWI650141B (zh) 包含奎寧鹽懸浮液的用於抗癌治療的局部給藥用注射劑組合物
ES2910021T3 (es) Composiciones que contienen apoecuorina y métodos de uso de las mismas para tratar la inflamación neuronal
CN112294811A (zh) 一种治疗胶质瘤的混合制剂
CN109481692A (zh) 一种青蒿琥酯肝素衍生物及其药物组合物和应用
CN108992463A (zh) 一种治疗肺癌的组合物及药物制剂
TW201444561A (zh) 可治療癌症之藥學組合物
CN101411700B (zh) 5,7,4'-三羟基二氢黄酮或其衍生物用于止痛的用途
CN108403701B (zh) 二氢雷公藤红素在制备预防或治疗血液肿瘤疾病的药物中的用途
RU2077888C1 (ru) Способ лечения лучевой болезни у животных
CN106581027B (zh) 一种化合物及其药物用途、组合物与制剂
US9872882B2 (en) Aurantiamide dipeptide derivatives for treatment or prevention of angiogenesis-related diseases

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20211109

EEER Examination request

Effective date: 20211109

EEER Examination request

Effective date: 20211109

EEER Examination request

Effective date: 20211109

EEER Examination request

Effective date: 20211109

EEER Examination request

Effective date: 20211109

EEER Examination request

Effective date: 20211109